A detailed history of Left Brain Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Left Brain Wealth Management, LLC holds 962 shares of LLY stock, worth $850,860. This represents 0.41% of its overall portfolio holdings.

Number of Shares
962
Previous 918 4.79%
Holding current value
$850,860
Previous $714 Million 21.96%
% of portfolio
0.41%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $31,894 - $39,997
44 Added 4.79%
962 $871 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $543,639 - $727,313
918 New
918 $714 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Left Brain Wealth Management, LLC Portfolio

Follow Left Brain Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Left Brain Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Left Brain Wealth Management, LLC with notifications on news.